{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:48:21Z","timestamp":1787755701336,"version":"build-2784847793"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/1475-2840-2-11","type":"journal-article","created":{"date-parts":[[2003,10,3]],"date-time":"2003-10-03T06:19:31Z","timestamp":1065161971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof"],"prefix":"10.1186","volume":"2","author":[{"given":"Enrique Z","family":"Fisman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Motro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Tenenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,9,12]]},"reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2337\/diab.44.4.369","volume":"44","author":"MP Stern","year":"1995","unstructured":"Stern MP: Diabetes and cardiovascular disease. The \"common soil\" hypothesis. Diabetes. 1995, 44: 369-374.","journal-title":"Diabetes"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1475-2840-2-4","volume":"2","author":"A Tenenbaum","year":"2003","unstructured":"Tenenbaum A, Fisman EZ, Motro M: Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR). Cardiovasc Diabetol. 2003, 2: 4-10.1186\/1475-2840-2-4.","journal-title":"Cardiovasc Diabetol"},{"key":"16_CR3","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1161\/01.CIR.100.10.1134","volume":"100","author":"SM Grundy","year":"1999","unstructured":"Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, Sowers JR: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999, 100: 1134-1146.","journal-title":"Circulation"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1046\/j.1365-2796.2002.01019.x","volume":"252","author":"GJ Blake","year":"2002","unstructured":"Blake GJ, Ridker PM: Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med. 2002, 252: 283-294. 10.1046\/j.1365-2796.2002.01019.x.","journal-title":"J Intern Med"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1056\/NEJM199408183310709","volume":"331","author":"RW Alexander","year":"1994","unstructured":"Alexander RW: Inflammation and coronary artery disease. New Engl J Med. 1994, 331: 468-469. 10.1056\/NEJM199408183310709.","journal-title":"New Engl J Med"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R: Atherosclerosis: an inflammatory disease. New Engl J Med. 1999, 340: 115-126. 10.1056\/NEJM199901143400207.","journal-title":"New Engl J Med"},{"key":"16_CR7","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation. 2002, 105: 1135-1143. 10.1161\/hc0902.104353.","journal-title":"Circulation"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1475-2840-2-5","volume":"2","author":"M Straczkowski","year":"2003","unstructured":"Straczkowski M, Kowalska I, Nikolajuk A, Dzienis-Straczkowska S, Szelachowska M, Kinalska I: Plasma interleukin 8 concentrations in obese subjects with impaired glucose tolerance. Cardiovasc Diabetol. 2003, 2: 5-10.1186\/1475-2840-2-5.","journal-title":"Cardiovasc Diabetol"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1161\/01.RES.0000061714.74668.5C","volume":"92","author":"S Srinivasan","year":"2003","unstructured":"Srinivasan S, Yeh M, Danziger EC, Hatley ME, Riggan AE, Leitinger N, Berliner JA, Hedrick CC: Glucose regulates monocyte adhesion through endothelial production of interleukin-8. Circ Res. 2003, 92: 371-377. 10.1161\/01.RES.0000061714.74668.5C.","journal-title":"Circ Res"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1053\/meta.2003.50096","volume":"52","author":"Y Moriwaki","year":"2003","unstructured":"Moriwaki Y, Yamamoto T, Shibutani Y, Aoki E, Tsutsumi Z, Takahashi S, Okamura H, Koga M, Fukuchi M, Hada T: Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism. 2003, 52: 605-608. 10.1053\/meta.2003.50096.","journal-title":"Metabolism"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1053\/euhj.2001.3052","volume":"23","author":"AD Pradhan","year":"2002","unstructured":"Pradhan AD, Ridker PM: Do atherosclerosis and diabetes share a common inflammatory basis?. Eur Heart J. 2002, 23: 831-834. 10.1053\/euhj.2001.3052.","journal-title":"Eur Heart J"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1146\/annurev.iy.09.040191.003525","volume":"9","author":"A Herman","year":"1991","unstructured":"Herman A, Kappler JW, Marrack P, Pullen AM: Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol. 1991, 9: 745-772.","journal-title":"Annu Rev Immunol"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00001432-200306000-00005","volume":"16","author":"M Gadina","year":"2003","unstructured":"Gadina M, Ferguson PR, Johnston JA: New interleukins: are there any more?. Curr Opin Infect Dis. 2003, 16: 211-217.","journal-title":"Curr Opin Infect Dis"},{"key":"16_CR14","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1128\/CMR.10.4.742","volume":"10","author":"JH Curfs","year":"1997","unstructured":"Curfs JH, Meis JF, Hoogkamp-Korstanje JA: A primer on cytokines: sources, receptors, effects, and inducers. Clin Microbiol Rev. 1997, 10: 742-780.","journal-title":"Clin Microbiol Rev"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1161\/01.CIR.89.5.2462","volume":"89","author":"HC Stary","year":"1994","unstructured":"Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW: A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994, 89: 2462-2478.","journal-title":"Circulation"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1046\/j.1464-5491.2002.00844.x","volume":"19","author":"A Kitamura","year":"2002","unstructured":"Kitamura A, Hasegawa G, Obayashi H, Kamiuchi K, Ishii M, Yano M, Tanaka T, Yamaguchi M, Shigeta H, Ogata M, Nakamura N, Yoshikawa T: Interleukin-6 polymorphism (-634C\/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes. Diabet Med. 2002, 19: 1000-1005. 10.1046\/j.1464-5491.2002.00844.x.","journal-title":"Diabet Med"},{"key":"16_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0065-2571(02)00036-5","volume":"43","author":"R Tenney","year":"2003","unstructured":"Tenney R, Turnbull JR, Stansfield KA, Pekala PH: The regulation of adipocyte metabolism and gene expression by interleukin-11. Adv Enzyme Regul. 2003, 43: 153-166. 10.1016\/S0065-2571(02)00036-5.","journal-title":"Adv Enzyme Regul"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1056\/NEJM199301143280207","volume":"328","author":"CA Dinarello","year":"1993","unstructured":"Dinarello CA, Wolff SM: The role of interleukin-1 in disease. N Engl J Med. 1993, 328: 106-113. 10.1056\/NEJM199301143280207.","journal-title":"N Engl J Med"},{"key":"16_CR19","first-page":"951","volume":"138","author":"PG Tipping","year":"1991","unstructured":"Tipping PG, Hancock WW: Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol. 1991, 138: 951-960.","journal-title":"Am J Pathol"},{"key":"16_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1136\/hrt.76.1.24","volume":"76","author":"D Hasdai","year":"1996","unstructured":"Hasdai D, Scheinowitz M, Leibovitz E, Sclarovsky S, Eldar M, Barak V: Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease. Heart. 1996, 76: 24-28.","journal-title":"Heart"},{"key":"16_CR21","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.2337\/diabetes.50.12.2721","volume":"50","author":"CD Major","year":"2001","unstructured":"Major CD, Wolf BA: Interleukin-1beta stimulation of c-Jun NH(2)-terminal kinase activity in insulin-secreting cells: evidence for cytoplasmic restriction. Diabetes. 2001, 50: 2721-2728.","journal-title":"Diabetes"},{"key":"16_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/clc.4960240315","volume":"24","author":"AD Simon","year":"2001","unstructured":"Simon AD, Yazdani S, Wang W, Schwartz A, Rabbani LE: Elevated plasma levels of interleukin-2 and soluble IL-2 receptor in ischemic heart disease. Clin Cardiol. 2001, 24: 253-256.","journal-title":"Clin Cardiol"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"735","DOI":"10.4049\/jimmunol.170.2.735","volume":"170","author":"W Zhou","year":"2003","unstructured":"Zhou W, Zhang F, Aune TM: Either IL-2 or IL-12 is sufficient to direct Th1 differentiation by nonobese diabetic T cells. J Immunol. 2003, 170: 735-740.","journal-title":"J Immunol"},{"key":"16_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0021-9150(96)05968-0","volume":"127","author":"HG Rus","year":"1996","unstructured":"Rus HG, Vlaicu R, Niculescu F: Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis. 1996, 127: 263-271. 10.1016\/S0021-9150(96)05968-0.","journal-title":"Atherosclerosis"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S0002-9343(99)00066-2","volume":"196","author":"TB Harris","year":"1999","unstructured":"Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH, Heimovitz H, Cohen HJ, Wallace R: Mortality risk associated with elevated interleukin-6 and C-reactive protein in old age. Am J Med. 1999, 196: 506-512. 10.1016\/S0002-9343(99)00066-2.","journal-title":"Am J Med"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/01.CIR.94.5.874","volume":"94","author":"LM Biasucci","year":"1996","unstructured":"Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A: Elevated levels of IL-6 in unstable angina. Circulation. 1996, 94: 874-877.","journal-title":"Circulation"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/01.CIR.99.7.855","volume":"99","author":"LM Biasucci","year":"1999","unstructured":"Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, Summaria F, Ginnetti F, Fadda G, Maseri A: Elevated levels of C-reactive protein at discharge predicts recurrent instability in patients with unstable angina. Circulation. 1999, 99: 855-860.","journal-title":"Circulation"},{"key":"16_CR28","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1161\/01.CIR.99.16.2079","volume":"99","author":"LM Biasucci","year":"1999","unstructured":"Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, Dinarello CA, Maseri A: Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation. 1999, 99: 2079-2084.","journal-title":"Circulation"},{"key":"16_CR29","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1046\/j.1464-5491.2003.00953.x","volume":"20","author":"D Rachon","year":"2003","unstructured":"Rachon D, Mysliwska J, Suchecka-Rachon K, Semetkowska-Jurkiewicz B, Zorena K, Lysiak-Szydlowska W: Serum interleukin-6 levels and bone mineral density at the femoral neck in post-menopausal women with Type 1 diabetes. Diabet Med. 2003, 20: 475-480. 10.1046\/j.1464-5491.2003.00953.x.","journal-title":"Diabet Med"},{"key":"16_CR30","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1161\/01.CIR.0000070542.18001.87","volume":"107","author":"JK Damas","year":"2003","unstructured":"Damas JK, Waehre T, Yndestad A, Otterdal K, Hognestad A, Solum NO, Gullestad L, Froland SS, Aukrust P: Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets. Circulation. 2003, 107: 2670-2676. 10.1161\/01.CIR.0000070542.18001.87.","journal-title":"Circulation"},{"key":"16_CR31","first-page":"RA5","volume":"8","author":"SM Saadeddin","year":"2002","unstructured":"Saadeddin SM, Habbab MA, Ferns GA: Markers of inflammation and coronary artery disease. Med Sci Monit. 2002, 8: RA5-12.","journal-title":"Med Sci Monit"},{"key":"16_CR32","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S1054-8807(02)00111-4","volume":"11","author":"BW Wong","year":"2002","unstructured":"Wong BW, Wong D, McManus BM: Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease. Cardiovasc Pathol. 2002, 11: 332-338. 10.1016\/S1054-8807(02)00111-4.","journal-title":"Cardiovasc Pathol"},{"key":"16_CR33","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/19546","volume":"398","author":"RE Gerszten","year":"1999","unstructured":"Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA, Luster AD, Luscinskas FW, Rosenzweig A: MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature. 1999, 398: 718-723. 10.1038\/19546.","journal-title":"Nature"},{"key":"16_CR34","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1046\/j.1365-2362.2002.01053.x","volume":"32","author":"E Romuk","year":"2002","unstructured":"Romuk E, Skrzep-Poloczek B, Wojciechowska C, Tomasik A, Birkner E, Wodniecki J, Gabrylewicz B, Ochala A, Tendera M: Selectin-P and interleukin-8 plasma levels in coronary heart disease patients. Eur J Clin Invest. 2002, 32: 657-661. 10.1046\/j.1365-2362.2002.01053.x.","journal-title":"Eur J Clin Invest"},{"key":"16_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1475-2840-2-3","volume":"2","author":"MD Baugh","year":"2003","unstructured":"Baugh MD, Gavrilovic J, Davies IR, Hughes DA, Sampson MJ: Monocyte matrix metalloproteinase production in Type 2 diabetes and controls \u2013 a cross sectional study. Cardiovasc Diabetol. 2003, 2: 3-10.1186\/1475-2840-2-3.","journal-title":"Cardiovasc Diabetol"},{"key":"16_CR36","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.4049\/jimmunol.165.6.3444","volume":"165","author":"XG Smith","year":"2000","unstructured":"Smith XG, Bolton EM, Ruchatz H, Wei X, Liew FY, Bradley JA: Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival. J Immunol. 2000, 165: 3444-3450.","journal-title":"J Immunol"},{"key":"16_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1055\/s-2002-19959","volume":"34","author":"H Rothe","year":"2002","unstructured":"Rothe H, Hausmann A, Kolb H: Immunoregulation during disease progression in prediabetic NOD mice: inverse expression of arginase and prostaglandin H synthase 2 vs. interleukin-15. Horm Metab Res. 2002, 34: 7-12. 10.1055\/s-2002-19959.","journal-title":"Horm Metab Res"},{"key":"16_CR38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4049\/jimmunol.162.1.577","volume":"162","author":"MA Antonysamy","year":"1999","unstructured":"Antonysamy MA, Fanslow WC, Fu F, Li W, Qian S, Troutt AB, Thomson AW: Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol. 1999, 162: 577-584.","journal-title":"J Immunol"},{"key":"16_CR39","doi-asserted-by":"publisher","first-page":"642","DOI":"10.4049\/jimmunol.169.2.642","volume":"169","author":"T Starnes","year":"2002","unstructured":"Starnes T, Broxmeyer HE, Robertson MJ, Hromas R: Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol. 2002, 169: 642-646.","journal-title":"J Immunol"},{"key":"16_CR40","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","volume":"19","author":"K Nakanishi","year":"2001","unstructured":"Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H: Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol. 2001, 19: 423-474. 10.1146\/annurev.immunol.19.1.423.","journal-title":"Annu Rev Immunol"},{"key":"16_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/01.CIR.0000020546.30940.92","volume":"106","author":"S Blankenberg","year":"2002","unstructured":"Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, Rupprecht HJ, AtheroGene Investigators: Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation. 2002, 106: 24-30. 10.1161\/01.CIR.0000020546.30940.92.","journal-title":"Circulation"},{"key":"16_CR42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/heart.88.3.296","volume":"88","author":"Y Naito","year":"2002","unstructured":"Naito Y, Tsujino T, Fujioka Y, Ohyanagi M, Okamura H, Iwasaki T: Increased circulating interleukin-18 in patients with congestive heart failure. Heart. 2002, 88: 296-297. 10.1136\/heart.88.3.296.","journal-title":"Heart"},{"key":"16_CR43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000057959","volume":"57","author":"S Frigerio","year":"2002","unstructured":"Frigerio S, Hollander GA, Zumsteg U: Functional IL-18 is produced by primary pancreatic mouse islets and NIT-1 beta cells and participates in the progression towards destructive insulitis. Horm Res. 2002, 57: 94-104. 10.1159\/000057959.","journal-title":"Horm Res"},{"key":"16_CR44","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S1053-2498(01)00386-2","volume":"21","author":"FJ Bijlsma","year":"2002","unstructured":"Bijlsma FJ, vanKuik J, Marcel BS, Tilanus GJ, deJonge N, Rozemuller EH, van den Tweel JG, Gmelig-Meyling FHJ, deWeger RA: Donor interleukin-4 promoter gene polymorphism influences allograft rejection after heart transplantation. J Heart Lung Transplant. 2002, 21: 340-346. 10.1016\/S1053-2498(01)00386-2.","journal-title":"J Heart Lung Transplant"},{"issue":"Supp 1","key":"16_CR45","doi-asserted-by":"publisher","first-page":"S216","DOI":"10.1111\/j.1432-2277.2000.tb02023.x","volume":"13","author":"E Van Hoffen","year":"2000","unstructured":"Van Hoffen E, Polen E, Robertus-Teunissen M, De Jonge N, Lahpor JR, Gmelig-Meyling FH, De Weger RA: High frequency of IL-4 producing helper T lymphocytes associated with a reduced incidence of heart allograft rejection. Transpl Int. 2000, 13 (Supp 1): S216-224. 10.1007\/s001470050328.","journal-title":"Transpl Int"},{"key":"16_CR46","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00125-002-0816-7","volume":"45","author":"S Schmid","year":"2002","unstructured":"Schmid S, Molteni A, Fuchtenbusch M, Naserke HE, Ziegler AG, Bonifacio E: Reduced IL-4 associated antibody responses to vaccine in early pre-diabetes:. Diabetologia. 2002, 45: 677-685. 10.1007\/s00125-002-0816-7.","journal-title":"Diabetologia"},{"key":"16_CR47","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0168-3659(03)00031-2","volume":"88","author":"M Lee","year":"2003","unstructured":"Lee M, Ko KS, Oh S, Kim SW: Prevention of autoimmune insulitis by delivery of a chimeric plasmid encoding interleukin-4 and interleukin-10. J Control Release. 2003, 88: 333-342. 10.1016\/S0168-3659(03)00031-2.","journal-title":"J Control Release"},{"key":"16_CR48","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1161\/01.CIR.0000065232.57371.25","volume":"107","author":"C Heeschen","year":"2003","unstructured":"Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, Zeiher AM, for the CAPTURE Study Investigators: Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation. 2003, 107: 2109-2114. 10.1161\/01.CIR.0000065232.57371.25.","journal-title":"Circulation"},{"key":"16_CR49","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1161\/01.ATV.19.3.611","volume":"19","author":"Z Mallat","year":"1999","unstructured":"Mallat Z, Heymes C, Ohan J, Faggin E, Leseche G, Tedgui A: Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol. 1999, 19: 611-616.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"16_CR50","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.2337\/diabetes.51.6.1931","volume":"51","author":"CA Gunnett","year":"2002","unstructured":"Gunnett CA, Heistad DD, Faraci FM: Interleukin-10 protects nitric oxide-dependent relaxation during diabetes: role of superoxide. Diabetes. 2002, 51: 1931-1937.","journal-title":"Diabetes"},{"key":"16_CR51","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/intimm\/13.6.825","volume":"13","author":"AJ Slavin","year":"2001","unstructured":"Slavin AJ, Maron R, Weiner HL: Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. Int Immunol. 2001, 13: 825-833. 10.1093\/intimm\/13.6.825.","journal-title":"Int Immunol"},{"key":"16_CR52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/cyto.2002.1033","volume":"18","author":"C Ancey","year":"2002","unstructured":"Ancey C, Corbi P, Froger J, Delwail A, Wijdenes J, Gascan H, Potreau D, Lecron JC: Secretion of IL-6, IL-11 and LIF by human cardiomyocytes in primary culture. Cytokine. 2002, 18: 199-205. 10.1006\/cyto.2002.1033.","journal-title":"Cytokine"},{"key":"16_CR53","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/00005344-200203000-00014","volume":"39","author":"L Sartiani","year":"2002","unstructured":"Sartiani L, De Paoli P, Lonardo G, Pino R, Conti AA, Cerbai E, Pelleg A, Belardinelli L, Mugelli A: Does recombinant human interleukin-11 exert direct electrophysiologic effects on single human atrial myocytes?. J Cardiovasc Pharmacol. 2002, 39: 425-434. 10.1097\/00005344-200203000-00014.","journal-title":"J Cardiovasc Pharmacol"},{"key":"16_CR54","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S0735-1097(02)02711-0","volume":"41","author":"R Nishio","year":"2003","unstructured":"Nishio R, Shioi T, Sasayama S, Matsumori A: Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus. J Am Coll Cardiol. 2003, 41: 340-345. 10.1016\/S0735-1097(02)02711-0.","journal-title":"J Am Coll Cardiol"},{"key":"16_CR55","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S0041-1345(00)02074-1","volume":"33","author":"N Verma","year":"2001","unstructured":"Verma N, He XY, Chen J, Robinson C, Boyd R, Tran G, Hall BM: Interleukin 12 delays allograft rejection: effect mediated via nitric oxide. Transplant Proc. 2001, 33: 416-417. 10.1016\/S0041-1345(00)02074-1.","journal-title":"Transplant Proc"},{"key":"16_CR56","first-page":"602","volume":"11","author":"B Li","year":"2000","unstructured":"Li B, Cao D, Xu H, Chang J, Zhou G, Tian J, Li D, Theze J, Wu C: Interleukin-12 induces gene expression in interleukin-2 stimulated human T lymphocytes. Eur Cytokine Netw. 2000, 11: 602-607.","journal-title":"Eur Cytokine Netw"},{"key":"16_CR57","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.2337\/diabetes.48.8.1522","volume":"48","author":"P Zaccone","year":"1999","unstructured":"Zaccone P, Phillips J, Conget I, Gomis R, Haskins K, Minty A, Bendtzen K, Cooke A, Nicoletti F: Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes. 1999, 48: 1522-1528.","journal-title":"Diabetes"},{"key":"16_CR58","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1006\/phrs.1998.0288","volume":"37","author":"S Masson","year":"1998","unstructured":"Masson S, Latini R, Bevilacqua M, Vago T, Sessa F, Torri M, Anesini A, Salio M, Pasotti E, Agnello D: Within-patient variability of hormone and cytokine concentrations in heart failure. Pharmacol Res. 1998, 37: 213-217. 10.1006\/phrs.1998.0288.","journal-title":"Pharmacol Res"},{"key":"16_CR59","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000069513","volume":"130","author":"N Matsumoto","year":"2003","unstructured":"Matsumoto N, Katoh S, Mukae H, Matsuo T, Takatsu K, Matsukura S: Critical role of IL-5 in antigen-induced pulmonary eosinophilia, but not in lymphocyte activation. Int Arch Allergy Immunol. 2003, 130: 209-215. 10.1159\/000069513.","journal-title":"Int Arch Allergy Immunol"},{"key":"16_CR60","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1183\/09031936.02.00005402","volume":"20","author":"C Pilette","year":"2002","unstructured":"Pilette C, Ouadrhiri Y, Van Snick J, Renauld JC, Staquet P, Vaerman JP, Sibille Y: Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9. Eur Respir J. 2002, 20: 1198-1205. 10.1183\/09031936.02.00005402.","journal-title":"Eur Respir J"},{"key":"16_CR61","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1006\/cimm.1996.0054","volume":"168","author":"NA Parada","year":"1996","unstructured":"Parada NA, Cruikshank WW, Danis HL, Ryan TC, Center DM: IL-16 and other CD4 ligand-induced migration is dependent upon protein kinase C. Cell Immunol. 1996, 168: 100-106. 10.1006\/cimm.1996.0054.","journal-title":"Cell Immunol"},{"key":"16_CR62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1182\/blood.V86.1.283.bloodjournal861283","volume":"86","author":"R Ford","year":"1995","unstructured":"Ford R, Tamayo A, Martin B, Niu K, Claypool K, Cabanillas F, Ambrus J: Identification of B-cell growth factors (interleukin-14; high molecular weight-B-cell growth factors) in effusion fluids from patients with aggressive B-cell lymphomas. Blood. 1995, 86: 283-293.","journal-title":"Blood"},{"key":"16_CR63","doi-asserted-by":"publisher","first-page":"47517","DOI":"10.1074\/jbc.M205114200","volume":"277","author":"J Parrish-Novak","year":"2002","unstructured":"Parrish-Novak J, Xu W, Brender T, Yao L, Jones C, West J, Brandt C, Jelinek L, Madden K, McKernan PA: Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem. 2002, 277: 47517-47523. 10.1074\/jbc.M205114200.","journal-title":"J Biol Chem"},{"key":"16_CR64","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.4049\/jimmunol.170.8.4111","volume":"170","author":"DS Mehta","year":"2003","unstructured":"Mehta DS, Wurster AL, Whitters MJ, Young DA, Collins M, Grusby MJ: IL-21 induces the apoptosis of resting and activated primary B cells. J Immunol. 2003, 170: 4111-4118.","journal-title":"J Immunol"},{"key":"16_CR65","doi-asserted-by":"publisher","first-page":"10144","DOI":"10.1073\/pnas.170291697","volume":"97","author":"L Dumoutier","year":"2000","unstructured":"Dumoutier L, Van Roost E, Colau D, Renauld JC: Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA. 2000, 97: 10144-10149. 10.1073\/pnas.170291697.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR66","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T: Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003, 421: 744-748. 10.1038\/nature01355.","journal-title":"Nature"},{"key":"16_CR67","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S1074-7613(01)00243-6","volume":"15","author":"MM Fort","year":"2001","unstructured":"Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S, Menon S, Clifford T, Hunte B, Lesley R: IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity. 2001, 15: 985-995.","journal-title":"Immunity"},{"key":"16_CR68","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ni873","volume":"4","author":"P Sheppard","year":"2003","unstructured":"Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J: IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol. 2003, 4: 63-68. 10.1038\/ni873.","journal-title":"Nat Immunol"},{"key":"16_CR69","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1517\/14712598.3.5.715","volume":"3","author":"R Cordoba-Rodriguez","year":"2003","unstructured":"Cordoba-Rodriguez R, Frucht DM: IL-23 and IL-27: new members of the growing family of IL-12-related cytokines with important implications for therapeutics. Expert Opin Biol Ther. 2003, 3: 715-723. 10.1517\/eobt.3.5.715.21226.","journal-title":"Expert Opin Biol Ther"},{"key":"16_CR70","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1006\/jaut.1997.0142","volume":"10","author":"A Ito","year":"1997","unstructured":"Ito A, Aoyanagi N, Maki T: Regulation of autoimmune diabetes by interleukin 3-dependent bone marrow-derived cells in NOD mice. J Autoimmun. 1997, 10: 331-338. 10.1006\/jaut.1997.0142.","journal-title":"J Autoimmun"},{"key":"16_CR71","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/0192-0561(93)90075-A","volume":"15","author":"D Weisensee","year":"1993","unstructured":"Weisensee D, Bereiter-Hahn J, Schoeppe W, Low-Friedrich I: Effects of cytokines on the contractility of cultured cardiac myocytes. Int J Immunopharmacol. 1993, 15: 581-587. 10.1016\/0192-0561(93)90075-A.","journal-title":"Int J Immunopharmacol"},{"key":"16_CR72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1475-2840-1-3","volume":"1","author":"MR Hayden","year":"2002","unstructured":"Hayden MR, Tyagi SC: Intimal redox stress: Accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy. Cardiovasc Diabetol. 2002, 1: 3-10.1186\/1475-2840-1-3.","journal-title":"Cardiovasc Diabetol"},{"key":"16_CR73","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1475-2840-2-2","volume":"2","author":"MR Hayden","year":"2003","unstructured":"Hayden MR, Tyagi SC: Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress. Cardiovasc Diabetol. 2003, 2: 2-10.1186\/1475-2840-2-2.","journal-title":"Cardiovasc Diabetol"},{"key":"16_CR74","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1161\/01.CIR.90.4.2126","volume":"90","author":"V Fuster","year":"1994","unstructured":"Fuster V: Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 1994, 90: 2126-2146.","journal-title":"Circulation"},{"key":"16_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-1-1","volume":"1","author":"D Aronson","year":"2002","unstructured":"Aronson D, Rayfield EJ: How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol. 2002, 1: 1-10.1186\/1475-2840-1-1.","journal-title":"Cardiovasc Diabetol"},{"key":"16_CR76","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","volume":"353","author":"L Hansson","year":"1999","unstructured":"Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmaki K, Dahlof B, de Faire U, Morlin C: Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet. 1999, 353: 611-616. 10.1016\/S0140-6736(98)05012-0.","journal-title":"Lancet"},{"key":"16_CR77","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000, 342: 145-153. 10.1056\/NEJM200001203420301.","journal-title":"N Engl J Med"},{"key":"16_CR78","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1161\/01.CIR.103.3.357","volume":"103","author":"DJ Freeman","year":"2001","unstructured":"Freeman DJ, Norrie J, Sattar N, Neely RD, Cobbe SM, Ford I, Isles C, Lorimer AR, Macfarlane PW, McKillop JH: Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation. 2001, 103: 357-362.","journal-title":"Circulation"},{"key":"16_CR79","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1161\/01.CIR.0000025403.20953.23","volume":"106","author":"SM Haffner","year":"2002","unstructured":"Haffner SM, Greenberg AS, Weston WM, Chen H, Williams K, Freed MI: Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation. 2002, 106: 679-684. 10.1161\/01.CIR.0000025403.20953.23.","journal-title":"Circulation"},{"key":"16_CR80","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1001\/jama.290.4.486","volume":"290","author":"JL Chiasson","year":"2003","unstructured":"Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, STOP-NIDDM Trial Research Group: Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003, 290: 486-494. 10.1001\/jama.290.4.486.","journal-title":"JAMA"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2840-2-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:40:05Z","timestamp":1726242005000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/1475-2840-2-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,12]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,12]]}},"alternative-id":["16"],"URL":"https:\/\/doi.org\/10.1186\/1475-2840-2-11","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,12]]},"assertion":[{"value":"10 September 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"11"}}